Barclays PLC Medi Wound Ltd. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.33 - $2.35 $1 - $2	-1 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$3.34 - $4.63 $3 - $4	1 New	1 $0
Q2 2021 Aug 13, 2021	SELL	$3.38 - $5.71 $1,943 - $3,283	-575 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$3.77 - $6.05 $2,167 - $3,478	575 New	575 $3,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $789M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.